You are here

Roche

Medtech research spending set to slow in 2022

EP Vantage

Tue, 07/5/22 - 10:57 am

Becton Dickinson

Boston Scientific

EssilorLuxottica

Siemens Healthineers

Roche, Pfizer top list of ESG leaders in patient groups' view, but many still think pharmas can do better

Endpoints

Thu, 06/30/22 - 10:17 pm

patient advocacy groups

Fierce NextGen: Despite another key trial failure, Alzheimer's therapy developers find reason for optimism

Fierce Biotech

Wed, 06/29/22 - 10:59 am

Alzheimer's disease

clinical trials

Big pharma’s key third-quarter data

EP Vantage

Tue, 06/28/22 - 10:37 am

Novo Nordisk vaccines

clinical trials

pneumococcal disease

rheumatoid arthritis

Up-and-down test sales and a bigger Medtronic: medtech in 2028

EP Vantage

Mon, 06/20/22 - 10:35 am

Wipeout: Roche's anti-amyloid attack on presymptomatic Alzheimer's ends in failure

Fierce Biotech

Thu, 06/16/22 - 10:40 am

Alzheimer's disease

Roche deal fails to Repare the licensing scene

EP Vantage

Tue, 06/14/22 - 11:02 am

Repare Therapeutics

Regeneron's Eylea could lose 30% of its patients to Roche's Vabysmo over the next year: analyst survey

Fierce Pharma

Mon, 06/13/22 - 09:46 pm

Roche keeps the faith in new cancer immunotherapy despite trial setbacks

BioPharma Dive

Tue, 06/7/22 - 10:30 am

clinical trials

ASCO: BioNTech's Roche-partnered cancer vaccine combo hints at survival benefit in prostate cancer

Fierce Biotech

Sun, 06/5/22 - 11:45 pm

cancer vaccines

pancreatic cancer

Biogen, Samsung Bioepis launch ranibizumab-nuna in US

Ophthalmology Today

Fri, 06/3/22 - 09:11 am

Samsung Bioepis

ranibizumab-nuna

retinal disease

Roche pays Repare $125M to join Big Pharma peers in cancer race

Fierce Biotech

Thu, 06/2/22 - 10:36 am

Repare Therapeutics

Who needs Humira? AbbVie projected to be the top pharma company by sales in 2028: analysts

Fierce Pharma

Wed, 06/1/22 - 10:15 am

Microcap's effort to take on Eylea with Avastin biosimilar faces significant FDA roadblock

Endpoints

Tue, 05/31/22 - 10:51 am

Outlook Therapeutics

wet age-related macular degeneration

Roche puts pressure on SMA rivals with new FDA approval

Pharmaforum

Tue, 05/31/22 - 10:33 am

PTC Therapeutics

Abbvie to become the biggest of pharmas in 2028

EP Vantage

Mon, 05/30/22 - 10:13 am

Bristol Myers Squibb

Roche trumpets new glofitamab data in lymphoma at ASCO

Pharmaforum

Fri, 05/27/22 - 10:24 am

bispecific antibodies

3 cancer drug studies to watch at next month’s ASCO meeting

BioPharma Dive

Thu, 05/26/22 - 10:47 pm

Gilead Sciences

Roche unveils three new monkeypox tests as cases rise

Endpoints

Wed, 05/25/22 - 11:38 pm

Diagnostics beat implants in the race to market

EP Vantage

Tue, 05/24/22 - 10:22 am

Pages